Jason Duncan

CIK 1741553 · See Remarks · last filed 2026-01-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

27

Lifetime Open-Market Net

-$1.03M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NMRA See Remarks $1.78 $0 4 2026-01-09
ALBIREO PHARMA, INC. (ALBO) Delisted Chief Legal Officer and GC 0 $44.15 $0 -$1.03M 23 2023-03-02

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-10-23 ALBIREO PHARMA, INC. (ALBO) Delisted Sell (S) −89 -$3.1K EDGAR
2020-09-10 ALBIREO PHARMA, INC. (ALBO) Delisted Mixed −500 -$98.1K EDGAR
2020-07-23 ALBIREO PHARMA, INC. (ALBO) Delisted Sell (S) −91 -$2.3K EDGAR
2020-04-24 ALBIREO PHARMA, INC. (ALBO) Delisted Sell (S) −92 -$1.6K EDGAR
2020-01-23 ALBIREO PHARMA, INC. (ALBO) Delisted Mixed −447 -$10.7K EDGAR
2019-01-24 ALBIREO PHARMA, INC. (ALBO) Delisted Grant (A) +5,000 $0 EDGAR
2018-06-11 ALBIREO PHARMA, INC. (ALBO) Delisted Grant (A) $0 EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.